openPR Logo
Press release

CRISPR-Based Diagnostics Market Driven by Rapid Detection Needs and Gene Editing Advances | OraSure Technologies, Inc., Mammoth Biosciences, Inc., Integrated DNA Technologies

08-04-2025 03:15 PM CET | Health & Medicine

Press release from: DataM intelligence 4 Market Research LLP

CRISPR-Based Diagnostics Market

CRISPR-Based Diagnostics Market

CRISPR-Based Diagnostics Market size reached US$ 3.04 Billion in 2024 and is expected to reach US$ 12.09 Billion by 2033, growing at a CAGR of 16.7% during the forecast period 2025-2033.

CRISPR-Based Diagnostics Market Report by DataM Intelligence offers a detailed assessment of the global pharmaceutical and healthcare landscape, highlighting market size, key players, and critical growth drivers. With the convergence of gene-editing and rapid diagnostics, growing applications in infectious disease detection and oncology, and innovations in point-of-care testing, the report delivers strategic insights for stakeholders in this cutting-edge diagnostics space from 2025 to 2033.

Download exclusive insights with our detailed sample report (Corporate Email ID gets priority access): https://www.datamintelligence.com/download-sample/crispr-based-diagnostics-market?ophp

CRISPR diagnostics leverage gene-editing tools for fast and accurate detection of infectious diseases and genetic conditions. This emerging market is gaining traction due to its precision, low cost, and potential for point-of-care use. Applications range from COVID-19 detection to oncology and rare disease diagnostics.

CRISPR-Based Diagnostics Market Competitors Overview:

OraSure Technologies, Inc., Mammoth Biosciences, Inc., Integrated DNA Technologies, GenScript, among others.

Important Industry Updates of 2023, 2024 and 2025:

✅ In January 2025, CrisprBits Private Limited inaugurated a state-of-the-art laboratory dedicated to advancing CRISPR-based diagnostic solutions. The new facility is focused on developing innovative diagnostics for rare diseases, including hospital-acquired infections and antimicrobial resistance, leveraging the precision and power of CRISPR gene editing technology to address critical gaps in current diagnostic capabilities.

Methodology and Scope

The CRISPR-Based Diagnostics Market Report is built on a rigorous research methodology that integrates primary interviews, expert insights, and validated secondary data from company reports, industry publications, and reliable databases. Utilizing both bottom-up and top-down approaches, the analysis ensures high data accuracy through triangulation. The report covers current market dynamics, growth opportunities, and key strategic developments across global and regional markets.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/crispr-based-diagnostics-market?ophp

CRISPR-Based Diagnostics Market Segments Overview:

∎ By Technique (Recombinase Polymerase Amplification (RPA), Loop-mediated Isothermal Amplification (LAMP), Others)
∎ By Product (Kits, Buffer Solutions, Software, Others)
∎ By Application (Infectious Diseases, Non-Infectious Diseases)
∎ By End User (Hospitals, Diagnostic Centers, Biotechnology Companies, Academic and Research Institutes, Others)

The infectious disease diagnostics segment dominates, particularly for pathogens like SARS-CoV-2, owing to CRISPR's rapid, accurate, and point-of-care diagnostic capabilities.

Regional Overview for CRISPR-Based Diagnostics Market:

⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

North America leads the CRISPR diagnostics space with strong biotech presence and innovation. Asia Pacific is the fastest growing, backed by academic research and funding support.

Looking for in-depth insights? Grab the full report: https://www.datamintelligence.com/buy-now-page?report=crispr-based-diagnostics-market?ophp

The Report Covers:

➡ In-depth analysis of the demand-supply gap, market size estimates, SWOT and PESTEL analysis, along with global market forecasts.
➡ Strategic recommendations with a focused go-to-market approach.
➡ An unbiased evaluation of overall market performance.
➡ Region- and country-specific insights, with customized reports available upon request.
➡ Identification of high-potential and niche segments and regions demonstrating strong growth prospects.

People Also Ask:

➤ What are the current global trends in sales, production, imports, and exports within the CRISPR-Based Diagnostics market?
➤ Who are the leading manufacturers, and what are their production volumes, pricing strategies, and revenue metrics?
➤ What are the major opportunities and challenges facing vendors in this market?
➤ Which product categories, applications, or end-user segments are contributing most to market growth and share?
➤ What are the primary factors driving and restraining growth in the CRISPR-Based Diagnostics market?

Unlock 360° Market Intelligence with 2 Days FREE Trial Access of DataM Subscription Now!: https://www.datamintelligence.com/reports-subscription?ophp

✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Pipeline Analysis For Drugs Discovery
✅ Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Competitive Landscape

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release CRISPR-Based Diagnostics Market Driven by Rapid Detection Needs and Gene Editing Advances | OraSure Technologies, Inc., Mammoth Biosciences, Inc., Integrated DNA Technologies here

News-ID: 4132004 • Views:

More Releases from DataM intelligence 4 Market Research LLP

North America Liquid Biopsy Market Fueled by Non-Invasive Cancer Diagnostics and Genomic Insights | Merck & Co, Inc, F. Hoffmann-La Roche AG, Exosome Diagnostics, Inc.
North America Liquid Biopsy Market Fueled by Non-Invasive Cancer Diagnostics and …
The North America liquid biopsy market was valued at US$ 1464.00 million in 2023 and is estimated to reach US$ 5110.34 million by 2031, growing at a CAGR of 17.1% during the forecast period from 2024-2031. North America Liquid Biopsy Market Report by DataM Intelligence offers a detailed assessment of the regional pharmaceutical and healthcare landscape, highlighting market size, key players, and critical growth drivers. With rising adoption of non-invasive diagnostic
Smart Hospital Beds Market Expands with Demand for Patient Safety and IoT-Enabled Monitoring | Baxter International, Inc., Stryker, LINET Group SE, Arjo, Amico Group of Companies
Smart Hospital Beds Market Expands with Demand for Patient Safety and IoT-Enable …
Smart Hospital Beds Market size reached US$ 3.28 Billion in 2024 and is expected to reach US$ 4.77 Billion by 2033, growing at a CAGR of 4.3% during the forecast period 2025-2033. Smart Hospital Beds Market Report by DataM Intelligence offers a detailed assessment of the global pharmaceutical and healthcare landscape, highlighting market size, key players, and critical growth drivers. With the growing push for patient-centric care, integration of IoT in
Cancer Biomarker Testing Market Grows with Precision Oncology and Early Detection Demand | Illumina, Inc., F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott
Cancer Biomarker Testing Market Grows with Precision Oncology and Early Detectio …
The global cancer biomarker testing market was valued at US$ 29.83 Billion in 2023. The market size reached US$ 33.37 Billion in 2024 and is expected to reach US$ 96.53 Billion by 2033, growing at a CAGR of 12.6% during the forecast period 2025-2033. Cancer Biomarker Testing Market Report by DataM Intelligence offers a detailed assessment of the global pharmaceutical and healthcare landscape, highlighting market size, key players, and critical
Recombinant Plasma Protein Therapeutics Market Driven by Hemophilia Treatment Innovations | Takeda Pharmaceuticals, CSL, Pfizer Inc., Novo Nordisk A/S.
Recombinant Plasma Protein Therapeutics Market Driven by Hemophilia Treatment In …
The global recombinant plasma protein therapeutics market reached US$ 34,774.78 million in 2023 and is expected to reach US$ 56,267.88 million by 2031, growing at a CAGR of 6.2% during the forecast period 2024-2031. Recombinant Plasma Protein Therapeutics Market Report by DataM Intelligence offers a detailed assessment of the global pharmaceutical and healthcare landscape, highlighting market size, key players, and critical growth drivers. With advancements in recombinant technologies, increasing prevalence of

All 5 Releases


More Releases for CRISPR

Amerigo Scientific Unveils CRISPR/Cas Enzymes to Expand the CRISPR Toolbox
Amerigo Scientific, as a distributor focused on providing critical products and services to biomedical and life science communities, announced the release of a groundbreaking selection of CRISPR/Cas enzymes to its extensive life science portfolio, aimed at further expanding the vast potential of the CRISPR toolbox. This addition brings cutting-edge genetic editing tools to scientists and researchers in a variety of fields. CRISPR/Cas (Clustered Regularly Interspaced Short Palindromic Repeats/CRISPR-associated) technology revolutionized the
CRISPR Technology Market - Gene Editing Redefined: Pioneering CRISPR Technology …
Newark, New Castle, USA: The "CRISPR Technology Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors CRISPR Technology Market: https://www.growthplusreports.com/report/crispr-technology-market/7632 This latest report researches the industry structure, sales,
CRISPR And CRISPR-Associated (Cas) Genes Market Analysis & Trends - Industry For …
LOS ANGELES, United States: The research study presented in this report offers a complete and intelligent analysis of the competition, segmentation, dynamics, and geographical advancement of the global CRISPR And CRISPR-Associated (Cas) Genes market. It takes into account the CAGR, value, volume, revenue, production, consumption, sales, manufacturing cost, prices, and other key factors related to the global CRISPR And CRISPR-Associated (Cas) Genes market. The authors of the report have segmented
CRISPR & Cas Genes Market Dynamic Growth Factors 2028 | CRISPR Therapeutics, Ast …
"CRISPR & Cas Genes Market" Report offers an in-depth analysis of the market size, share, SWOT Analysis, future progress expansion, industry growth, key development strategies and market trend dynamics which includes drivers, restraints, opportunities prevailing in the industry by product type, application, key manufacturers and key regions and countries. It also offers advanced statistics as well as some business-driven information associated with the precise industry. It delivers an analytical investigation of the
CRISPR and CRISPR-Associated (Cas) Genes Market 2022 | Detailed Report
According to Market Study Report, CRISPR and CRISPR-Associated (Cas) Genes Market provides a comprehensive analysis of the CRISPR and CRISPR-Associated (Cas) Genes Market segments, including their dynamics, size, growth, regulatory requirements, competitive landscape, and emerging opportunities of global industry. An exclusive data offered in this report is collected by research and industry experts team. Download FREE Sample Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=4240401 The report provides a comprehensive analysis of company profiles listed below: -
CRISPR and CRISPR-Associated (Cas) Genes Market 2021 | Detailed Report
The CRISPR and CRISPR-Associated (Cas) Genes research report undoubtedly meets the strategic and specific needs of the businesses and companies. The report acts as a perfect window that provides an explanation of market classification, market definition, applications, market trends, and engagement. The competitive landscape is studied here in terms of product range, strategies, and prospects of the market’s key players. Furthermore, the report offers insightful market data and information about